<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This study was aimed to investigate the expression of CCAAT/enhancer binding protein alpha gene (c/ebpα) in patients with <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) and to explore the significance of c/ebpα in pathogenesis and progression of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Real time quantitative reverse transcriptase polymerase chain reaction (RQ-PCR) method was used to detect the expression level of c/ebpα <z:chebi fb="2" ids="33699">mRNA</z:chebi> in bone marrow mononuclear cells (BMMNC) of 33 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and 14 <z:mpath ids='MPATH_458'>normal</z:mpath> controls </plain></SENT>
<SENT sid="2" pm="."><plain>The results showed that the expression level of c/ebpα <z:chebi fb="2" ids="33699">mRNA</z:chebi> in low-risk and high-risk <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> was significantly lower than that of <z:mpath ids='MPATH_458'>normal</z:mpath> controls (p &lt; 0.01, p &lt; 0.001, respectively), moreover, high-risk <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> showed lower c/ebpα <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression compared with low-risk <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> (p &lt; 0.05). c/ebpα <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression level in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> was not correlated with sex, age and peripheral blood cell amount, while the ratio of blast cells in bone marrow was in the c/ebpα <z:chebi fb="2" ids="33699">mRNA</z:chebi> low expression group significantly higher than that in the high expression group (p &lt; 0.01) </plain></SENT>
<SENT sid="3" pm="."><plain>It is concluded that down-regulation of c/ebpα <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression level has closely associated with the pathogenesis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, the c/ebpα may be an important molecular biological marker of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>; the degree of down-regulated c/ebpα has closely related to the progression of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
</text></document>